Understand the source comparison
Semax Amidate for Neuroprotection: Research Model Comparison
The table below compares neuroprotective efficacy of Semax Amidate across different research models, including optimal dosing ranges, measurable endpoints, and key mechanistic distinctions. Acute Ischemic Injury (MCAO) 50–100 mcg/kg within 6 hours of occlusion
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares neuroprotective efficacy of Semax Amidate across different research models, including optimal dosing ranges, measurable endpoints, and key mechanistic distinctions.
- Acute Ischemic Injury (MCAO)
- 50–100 mcg/kg within 6 hours of occlusion
- Infarct volume reduction (TTC staining, 72h)
- 35–42% reduction vs vehicle control
- BDNF upregulation activates PI3K/Akt survival pathway; reduces apoptosis in penumbral region
- Most robust neuroprotective effect; therapeutic window extends to 12 hours with diminished but measurable benefit (18–24% reduction)
- Oxidative Stress (H₂O₂, 6-OHDA)
- 10–50 μM in vitro; 50 mcg/kg in vivo
- Cell viability (MTT assay); ROS markers (MDA, 4-HNE)
- 28–36% reduction in cell death; 28–36% reduction in lipid peroxidation
- Upregulation of antioxidant enzymes (SOD, catalase, GPx) via BDNF-TrkB signaling
- Protection requires intact BDNF signaling (abolished by TrkB blockade); not a direct ROS scavenger
- Age-Related Cognitive Decline
- 50 mcg/kg daily for 21 days
- Morris water maze latency; dendritic spine density (Golgi-Cox staining)
- 32–41% improvement in spatial memory; 18–24% increase in spine density
- Sustained BDNF elevation (1.3–1.7-fold above baseline) preserves synaptic plasticity
- Chronic dosing required for structural synaptic changes; acute bolus insufficient for long-term cognitive preservation
- Glutamate Excitotoxicity
- 10–25 μM pre-treatment or co-treatment
- Neuronal survival (immunocytochemistry, 24h)
- 28–34% reduction in excitotoxic cell death
- BDNF upregulation enhances calcium buffering capacity; reduces NMDA receptor overactivation
- Pre-treatment more effective than post-exposure administration; suggests prophylactic rather than rescue mechanism